Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) fell 10.8% during mid-day trading on Monday . The stock traded as low as GBX 1.69 and last traded at GBX 1.69. 350,297 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 1,338,121 shares. The stock had previously closed at GBX 1.90.
Cizzle Biotechnology Trading Up 4.1%
The company has a fifty day moving average of GBX 1.59 and a 200-day moving average of GBX 1.58. The company has a market capitalization of £7.02 million, a price-to-earnings ratio of -5.53 and a beta of 0.38.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last released its earnings results on Tuesday, September 30th. The company reported GBX (0.09) earnings per share for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- How to Short a Stock in 5 Easy Steps
- onsemi Places a $6 Billion Bet on Its Own Stock
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- How Investors Can Find the Best Cheap Dividend Stocks
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
